NEFL and Parkinson disease: The study included 152 PD patients, and showed that NfL levels in plasma and CSF predicted change in cross-sectional associations between NfL and the Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) and Mattis Dementia Rating Scale (DRS-2) scores using linear mixed-effects models.